ADMdx Logo

ADMdx Authors Chapter in New Book on the Alzheimer’s Drug Development Ecosystem

March 31, 2022

Led by editors Dr. Jeffrey Cummings, Dr. Jeffrey Kinney and Dr. Howard Fillit, the book Alzheimer's Disease Drug Development: Research and Development Ecosystem has been published. Dawn Matthews, ADMdx CEO, was selected to be the primary author of the chapter on neuroimaging in Alzheimer’s Disease clinical trials. This book provides a comprehensive overview of the many facets of drug development for Alzheimer’s disease, and discusses approaches that could help to address the high failure rate of clinical trials. The book is available through multiple sources including

ADMdx Logo
©2023. CorInsights® MRI is a registered trademark of AMDdx, 555 Skokie Blvd, Suite 500, Northbrook, IL, 60062, USA.